Playback speed
10 seconds
BCL2 Inhibition in Myeloid Malignancies: Venetoclax + Azacitidine in AML and MDS & Navitoclax and Ruxolitinib in Ph-MPNs
By
UChicago Annual Updates from ASH 2019
FEATURING
Olatoyosi Odenike
By
UChicago Annual Updates from ASH 2019
FEATURING
Olatoyosi Odenike
287 views
March 20, 2020
Login to view comments.
Click here to Login